These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6846084)

  • 1. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions.
    Puchstein C; van Aken H; Hidding J; Anger C; Lawin P
    Acta Neurochir (Wien); 1983; 67(3-4):283-90. PubMed ID: 6846084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of labetalol on intracranial pressure in dogs with and without intracranial hypertension.
    Van Aken H; Puchstein C; Schweppe ML; Heinecke A
    Acta Anaesthesiol Scand; 1982 Dec; 26(6):615-9. PubMed ID: 7158271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension.
    Van Aken H; Puchstein C; Anger C; Lawin P
    Intensive Care Med; 1983; 9(3):123-6. PubMed ID: 6863721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage.
    Qureshi AI; Wilson DA; Hanley DF; Traystman RJ
    Crit Care Med; 1999 May; 27(5):965-71. PubMed ID: 10362421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
    Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
    Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of labetalol in producing deliberate hypotension and its effects on intracranial pressure in dogs.
    Van Aken H; Puchstein C; Hidding J
    Acta Anaesthesiol Belg; 1982; 33(1):5-12. PubMed ID: 7090725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension].
    Koch G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():219-20. PubMed ID: 349925
    [No Abstract]   [Full Text] [Related]  

  • 9. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 11. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
    Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension in the elderly with labetalol.
    Sirgo MA; Boyd BK; Applegate WB
    Pharmacotherapy; 1989; 9(5):295-302. PubMed ID: 2682551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
    Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of combined alpha and beta blockade with labetalol on the haemodynamics of stress reaction in hypertensives (author's transl)].
    Bahlmann J; Brod J; Hubrich W; Pretschner P
    Dtsch Med Wochenschr; 1980 Oct; 105(41):1414-8. PubMed ID: 7449643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.